Current status and future directions of anti-angiogenic therapy for gliomas - Wikidata - awgldk - TriplyDB

Current status and future directions of anti-angiogenic therapy for gliomas

Current status and future directions of anti-angiogenic therapy for gliomas

http://www.wikidata.org/entity/Q36618235

about

Glioblastoma targeted therapy: updated approaches from recent biological insights.Study of angiogenic signaling pathways in hemangioblastoma.Medical Imaging Informatics.Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma.Angiogenesis inhibitors in tackling recurrent glioblastoma.Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights Glioblastoma in elderly patients: solid conclusions built on shifting sand?Activation of multiple angiogenic signaling pathways in hemangiopericytoma.The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?

P2860

Q38597700-C2F50113-39D6-40E1-9DE8-D140D609B9B3 Q38844258-8AACD1BB-B0EF-4F19-BC67-D490311C3B70 Q38997187-B20CBB36-FD80-4C7F-B31A-081561E8FB33 Q39211981-AE7F78B8-D39C-44AA-B9C8-9F9E45F0EC28 Q39259089-A158C4CD-2408-407C-AF2F-1E2F32EAF531 Q40439684-C58F9D9D-D703-4F51-8602-65D68629C377 Q47827482-A0BA78B2-AFEA-4573-B337-CFB188852B5D Q48854018-F6B954A1-5D9D-47AD-B42C-AF53114EE886 Q49164272-8B1E3550-FDAE-4C37-A376-9E667F5A1101 Q55362761-F39E2874-8F5F-40AA-81D0-284A9CAE9F59 Q55711736-A1FDC566-EB73-4D9C-BD3B-1FB4678EC7B0

P2860

Current status and future directions of anti-angiogenic therapy for gliomas

http://www.wikidata.org/entity/Q36618235

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Current status and future directions of anti-angiogenic therapy for gliomas

@ast

Current status and future directions of anti-angiogenic therapy for gliomas

@en

type

label

Current status and future directions of anti-angiogenic therapy for gliomas

@ast

Current status and future directions of anti-angiogenic therapy for gliomas

@en

prefLabel

Current status and future directions of anti-angiogenic therapy for gliomas

@ast

Current status and future directions of anti-angiogenic therapy for gliomas

@en

P1433

Q36618235-620E88F4-2970-4EE9-B9C4-582382469A48

P1476

Q36618235-02BB393B-B757-4334-8307-1318904F0A98

P2093

Q36618235-0EA6D14B-4212-4779-95CF-483257B88D4B

Q36618235-3757A016-83A1-43D3-A0EB-7C36B3E5ED42

Q36618235-6301B5B7-217C-4C2B-B851-9CD663FD047D

P2860

Q36618235-01A32291-145D-4C2A-B016-8AA1EC5E07F7

Q36618235-0237EEE5-6B8A-408A-B232-E165DFB432C1

Q36618235-04899555-E829-4CF7-B1DD-64B72667664C

Q36618235-0598083C-F31F-4E43-B0E7-39FCD4267B92

Q36618235-05B9363F-EA60-4F56-9B11-C8B631E70C14

Q36618235-09446F50-6F57-4ED2-900E-EDE33B23256E

Q36618235-0C158F90-BA8F-49CA-ABFD-4B1730E41DCE

Q36618235-14DDAA4D-0EF8-4670-96F3-000A3D460E1E

Q36618235-15D94FFC-E8D1-4569-B841-615C15E9AE47

Q36618235-18C82A5A-6B16-44EA-AC50-88C88902C6D4

P304

Q36618235-0199C32A-05ED-46FB-B93D-93576200E852

P31

Q36618235-D2AEA91B-58D7-4743-B18D-C4E4BF700683

P356

Q36618235-407D4006-1402-49E7-AC42-56CE16B41F8F

P433

Q36618235-22994FE7-17F0-4231-B79F-BEB92CD06B97

P478

Q36618235-0C72F90E-23C8-4ED2-B7B1-64D5AD9A6432

P50

Q36618235-0352E09D-AA4D-4775-A378-C18D6D2CD768

Q36618235-8CC4E09E-CB6F-4D70-B90C-EE2F9904BEE2

Q36618235-C2EFA555-717F-4653-AA7F-960A2F03EB49

Q36618235-ECDE391A-6958-408D-9000-A6A2C007923D

P577

Q36618235-81888E05-3619-43B3-809C-0EF915AEDE83

P5875

Q36618235-F31E2F18-4DD8-4E2F-8083-2D8DBDDD3683

P698

Q36618235-BD9AABA0-DE8D-4E83-82B9-2FA9F787213D

P932

Q36618235-C45A6494-6A1F-4BFD-B21C-397DD2CE6CBD

P356

P1433

P1476

Current status and future directions of anti-angiogenic therapy for gliomas

@en

P2093

Anne Hertenstein

http://www.w3.org/2001/XMLSchema#string

Antje Wick

http://www.w3.org/2001/XMLSchema#string

Frank Winkler

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Immunotherapy advances for glioblastoma

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.

Tumor angiogenesis: therapeutic implications

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Defining the role of mTOR in cancer

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

P304

315-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOV180

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Michael Platten

Martin Bendszus

Alexander Radbruch

P577

2015-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282874764

http://www.w3.org/2001/XMLSchema#string

P698

26459812

http://www.w3.org/2001/XMLSchema#string

P932

4767238

http://www.w3.org/2001/XMLSchema#string